FindTrial
Sign In

To evaluate the role of prolactin in guiding antibiotic treatment in patients with severe acute pancreatitis

Role of Procalcitonin in guiding antibiotic therapy in moderate to severe acute pancreatitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/062457
Enrollment
96
Registered
2024-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K869- Disease of pancreas, unspecified

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with the confirm diagnosis of moderate and severe acute pancreatitis

Exclusion criteria

Exclusion criteria: Admitted after 1 week of acute pancreatitis Patient on antibiotic

Design outcomes

Primary

MeasureTime frame
To assess the procalcitonin level for Antibiotic usage during the admission periodTimepoint: 0,7,14 days—

Secondary

MeasureTime frame
Profile of infection, intervention and outcome in moderate to severe acute pancreatitisTimepoint: 0,7,14 days—

Countries

India

Contacts

Public ContactDr V S Mohammed Fazil
bhat.ganesh@manipal.edu9900791615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026